Cite

    Zhang, Z. et al. (2020). Pretreatment hemoglobin level as a predictor to evaluate the efficacy of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer. Therapeutic advances in medical oncology. p. . [Online].